Dr. Jingjing Zhang, MD

Dr. Zhang practices at Pdi Walnut Tower in Philadelphia, Pennsylvania.

Dr. Zhang's NPI, 1437386141, was assigned on June 19, 2009. Dr. Zhang holds Pennsylvania license MD451690.

Dr. Zhang's primary practice is Pdi Walnut Tower, at 4126-38 Walnut St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 629-1490.

Dr. Zhang's primary practice is Pdi Walnut Tower in Philadelphia, Pennsylvania. Dr. Zhang is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Zhang to 1 more hospital, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhang practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Zhang's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Zhang's licenses on file in 2 states: Pennsylvania and Massachusetts.

CMS data shows 635 Medicare services from Dr. Zhang across 9 procedure codes in 2024, for 252 Medicare patients. Medicare paid $65,298 for them.

CMS counts 252 Medicare patients who saw Dr. Zhang in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 37% are also on Medicaid. Their average risk score is 4.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zhang's median patient age at 68, with 49% women.

In 2024, Dr. Zhang wrote 853 Medicare Part D claims for 144 patients. 88% of them were for generic drugs. CMS names the drug for 691 of them, across 21 drugs with 11 or more claims each, at $61,989 in total drug cost. In 2023, CMS named 774 claims across 25 drugs.

Dr. Zhang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zhang as offering telehealth.

Dmand AI links 14 papers to Dr. Zhang, published from 2015 to 2024. 2015 was the busiest year, with 2. The most frequent topics are Anemia, Sickle Cell, Antigens, CD34 and Fetal Hemoglobin. Dr. Zhang has published most often in J Nat Prod. Dr. Zhang's most frequent co-authors are Mitchell J. Weiss, MD, Yu Yao, MD and Senthil Velan Bhoopalan, MBBS, PhD.

CMS Open Payments shows 12 general payments to Dr. Zhang from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Relypsa, Inc. paid the most, $376.